Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 13, 2002

View Archived Issues

Telomerase inhibitors under study at Pharmacia

Novel 5-HT6 ligands for depression, anxiety, cognitive disorders, etc., claimed in recent patent

AstraZeneca team identifies kappa opioid agonists

TLK-286 enters two new combination trials

Amended phase II protocol for FM-VP4

Argenta Discovery and Amedis extend collaboration

Provectus acquires company recently split from Photogen

Milnacipran improves FMS pain and fatigue in preliminary analysis

Phase III Ampligen trial in CFS completes enrollment

Paladin returns Canadian DepoCyt rights to SkyePharma

Pharmexa and Lundbeck Alzheimer's collaboration achieves proof of concept in animals

Minimal toxicity reported for SGN-30 in Hodgkin's disease and lymphoma

Potential use of MLN-518 in AML and high-risk MDS

Significant improvement reported on eculizumab in patients with paroxysmal nocturnal hemoglobinuria

Reduced liver iron content in thalassemic patients treated with ICL-670

Comparison of warfarin and idraparinux sodium in deep vein thrombosis

New cephem antibiotics discovered jointly by Fujisawa and Wakunaga

Series of 5-HT1A antagonists in early development at Wyeth

KuDOS and Maybridge claim isoquinoline-based PARP inhibitors

New tyrosine kinase inhibitors and their use in proliferative disorders

Veronate granted fast track status

Helix BioPharma completes acquisition of minority interest in Sensium

Medicure enters research collaboration with university group for NHE inhibitors

GSK identifies novel 5-HT7 receptor antagonist with good pharmacokinetic properties

Fully human MAb to human VEGFR-3 designed at ImClone Systems

Pharmacological profile of VX-944, an IMPDH inhibitor, characterized at ASH meeting

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...